Victoria Shender

7PUBLICATIONS
37CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Genome structure and regulationAutonomic nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 26, 2026
The Regulatory Network of FOXM1: Orchestrating Cancer Progression and Resistance to Therapy.

|Jan 08, 2025
Establishment of Novel High-Grade Serous Ovarian Carcinoma Cell Line OVAR79.

Polina V Shnaider, Irina K Malyants, Olga M Ivanova

|Jul 31, 2024
Author Correction: Therapy-induced secretion of spliceosomal components mediates pro-survival crosstalk between ovarian cancer cells.

Victoria O Shender, Ksenia S Anufrieva, Polina V Shnaider

|Jun 19, 2024
Therapy-induced secretion of spliceosomal components mediates pro-survival crosstalk between ovarian cancer cells.

Victoria O Shender, Ksenia S Anufrieva, Polina V Shnaider

|Oct 21, 2022
Splicing factor BUD31 promotes ovarian cancer progression through sustaining the expression of anti-apoptotic BCL2L12.

Zixiang Wang, Shourong Wang, Junchao Qin

|Oct 03, 2022
Alternative RNA splicing modulates ribosomal composition and determines the spatial phenotype of glioblastoma cells.

Tatyana D Larionova, Soniya Bastola, Tatiana E Aksinina

Pageof 2

Frequent Collaborators

3 joint publications

Andrey V Slonov

3 joint publications

Grigory Stepanov

3 joint publications

Marat S Pavlyukov

3 joint publications

Zixiang Wang